Form 8-K - Current report:
SEC Accession No. 0001558370-19-002208
Filing Date
2019-03-18
Accepted
2019-03-18 07:15:33
Documents
30
Period of Report
2019-03-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 33525
2 EX-99.1 ex-99d1.htm EX-99.1 208698
3 EX-99.2 ex-99d2.htm EX-99.2 33682
4 GRAPHIC ex-99d1g001.jpg GRAPHIC 17887
5 GRAPHIC ex-99d2g001.jpg GRAPHIC 245840
6 GRAPHIC ex-99d2g002.jpg GRAPHIC 339263
7 GRAPHIC ex-99d2g003.jpg GRAPHIC 230908
8 GRAPHIC ex-99d2g004.jpg GRAPHIC 126697
9 GRAPHIC ex-99d2g005.jpg GRAPHIC 154091
10 GRAPHIC ex-99d2g006.jpg GRAPHIC 358153
11 GRAPHIC ex-99d2g007.jpg GRAPHIC 341350
12 GRAPHIC ex-99d2g008.jpg GRAPHIC 357851
13 GRAPHIC ex-99d2g009.jpg GRAPHIC 174071
14 GRAPHIC ex-99d2g010.jpg GRAPHIC 335951
15 GRAPHIC ex-99d2g011.jpg GRAPHIC 347942
16 GRAPHIC ex-99d2g012.jpg GRAPHIC 313593
17 GRAPHIC ex-99d2g013.jpg GRAPHIC 182353
18 GRAPHIC ex-99d2g014.jpg GRAPHIC 323714
19 GRAPHIC ex-99d2g015.jpg GRAPHIC 304047
20 GRAPHIC ex-99d2g016.jpg GRAPHIC 308404
21 GRAPHIC ex-99d2g017.jpg GRAPHIC 248868
22 GRAPHIC ex-99d2g018.jpg GRAPHIC 186949
23 GRAPHIC ex-99d2g019.jpg GRAPHIC 235549
24 GRAPHIC ex-99d2g020.jpg GRAPHIC 118126
25 GRAPHIC ex-99d2g021.jpg GRAPHIC 311767
26 GRAPHIC ex-99d2g022.jpg GRAPHIC 286330
27 GRAPHIC ex-99d2g023.jpg GRAPHIC 297908
28 GRAPHIC ex-99d2g024.jpg GRAPHIC 288678
29 GRAPHIC ex-99d2g025.jpg GRAPHIC 258846
30 GRAPHIC ex-99d2g026.jpg GRAPHIC 240372
  Complete submission text file 0001558370-19-002208.txt   9833308
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 19686800
SIC: 2834 Pharmaceutical Preparations